WCM
CRL icon

Winton Capital Management’s Charles River Laboratories CRL Stock Holding History

Winton Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$716K Buy
11,870
+1,034
+10% +$60.3K ﹤0.01% 563
2013
Q4 		$575K Sell
10,836
-2,188
-17% -$110K 0.01% 603
2013
Q3 		$602K Sell
13,024
-4,928
-27% -$226K 0.01% 584
2013
Q2 		$737K Buy
+17,952
New +$769K 0.01% 553

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Winton Capital Management's CRL Position: Q1 2014 in Review

Winton Capital Management increased its Charles River Laboratories (CRL) stake by 9.5% in Q1 2014, buying an estimated $60.3K and bringing the position to 11,870 shares worth $716K. The position accounts for ﹤0.01% of the portfolio, ranked #563.

Winton Capital Management first reported a position in CRL in Q2 2013 and has held it in 4 quarters since. The position peaked at $737K in Q2 2013. 258 funds tracked by Wall St. Rank hold CRL as of Q1 2014.

  • Winton Capital Management held 11,870 shares of Charles River Laboratories worth $716K as of Q1 2014.
  • Winton Capital Management bought 1,034 Charles River Laboratories shares in Q1 2014, an estimated $60.3K.
  • Charles River Laboratories made up ﹤0.01% of Winton Capital Management's portfolio in Q1 2014, its #563 holding.
  • Winton Capital Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 4 quarters since.
  • Winton Capital Management's Charles River Laboratories position peaked at $737K in Q2 2013.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.